CAMBRIDGE, Mass., July 29, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today announced that Vito J. Palombella, Chief Scientific Officer, will present a company overview at the BMO 10th Annual Focus on Health Care Conference on Thursday, August 5, 2010 at 10:45 a.m. EDT in New York City.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.infi.com and will be archived on the website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and PI-3 kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.